A longitudinal study analyzing effect of Tozinameran and Coronavac boosters on humoral and cellular immunity of individuals who are previously fully vaccinated
Latest Information Update: 25 Apr 2022
At a glance
- Drugs SARS-COV-2 vaccine-inactivated-Sinovac-Biotech (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
Most Recent Events
- 25 Apr 2022 New trial record
- 19 Apr 2022 Results published in the Allergy